Legal Opinion
Allergan, Inc. v. Revance Therapeutics, Inc.
District Court, D. Delaware
Decided July 21, 2022No. 1:21-cv-01411Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) ALLERGAN, INC., ALLERGAN ) PHARMACEUTICALS IRELAND ) UNLIMITED COMPANY, and ALLERGAN ) USA, INC., ) ) Plaintiffs, ) ) v. ) C.A. No. 21-1411-RGA ) REVANCE THERAPEUTICS, INC. and ) AJINOMOTO ALTHEA, INC. d/b/a ) AJINOMOTO BIO-PHARMA SERVICES, ) ) Defendants. ) ) REPORT AND RECOMMENDATION Presently pending before the Court is Defendants’ Motion to Dismiss the First Amended Complaint Under Federal Rule of Civil Procedure 12(b)(1) and/or Rule 12(b)(6). (D.I. 22.) As announced from the bench on July 7, 2022, I recommend that…
2Cases cited21 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Aetna Life Insurance v. HaworthSupreme Court of the United States · 1937
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
- Constitution Party of Pennsylv v. Carol AicheleCourt of Appeals for the Third Circuit · 2014
16 more not listed; retrieve them via the Exa API.